Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins

Aphios Corporation today announced that it received notification of allowance for a United States Patent entitled “Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein” for the oral delivery of insulin.

With completion of the human genome sequence, the growth of the biotechnology marketplace is expanding rapidly. One of the major factors limiting the marketability and industrialization of biotechnology drugs is the method of delivery. These macromolecules are usually very effective when they can get to the disease site. They are also, for the most part, nontoxic since they mostly mimic human proteins. Unfortunately, these molecules, like insulin, are quite large and are most readily delivered by daily injections or intravenously in a hospital setting. These macromolecules are all candidates for improved oral, patch and pulmonary drug delivery.

“Aphios is enhancing the oral bioavailability of therapeutic proteins by encapsulating protein macromolecules and nanoparticles in biodegradable polymer nanospheres,” says Dr. Trevor P. Castor, President & CEO, Aphios Corporation. Nanoencapsulation is being used to protect the protein macromolecules/nanoparticles during the stomach passage; the residence time in the stomach will be short compared to the protein release rate from the polymer nanospheres. Animal data demonstrates that insulin, a labile peptide, being nanoencapsulated was protected in the stomach and then transported to the blood. When protein nanoparticles reach the gut, they are transported across the lining, which may be mediated by M cells in the lymphatic tissue of the gut. Alternatively, the protein can be mobilized from nanospheres and rapidly transported to systemic circulation by the epithelial cells. Both the polymer “shell” and the protein macromolecules/nanoparticles are intended to enable and regulate this stage of drug transport. With the optimal combination of the biodegradable polymer nanospheres shell properties and protein characteristics, we anticipate a significant improvement in oral bioavailability of protein therapeutics. We believe that our oral delivery nanotechnology will be applicable to large as well small protein molecules since we have demonstrated that our protein nanoparticles technology is independent of size and molecular weight (MW).

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Aphios Corporation. (2019, February 11). Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins. AZoNano. Retrieved on October 31, 2024 from https://www.azonano.com/news.aspx?newsID=26206.

  • MLA

    Aphios Corporation. "Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins". AZoNano. 31 October 2024. <https://www.azonano.com/news.aspx?newsID=26206>.

  • Chicago

    Aphios Corporation. "Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins". AZoNano. https://www.azonano.com/news.aspx?newsID=26206. (accessed October 31, 2024).

  • Harvard

    Aphios Corporation. 2019. Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins. AZoNano, viewed 31 October 2024, https://www.azonano.com/news.aspx?newsID=26206.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.